Form 4: Hims & Hers Health CFO Oluyemi Okupe Reports Stock Option Exercise
SEC Form 4 Filing
Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. exercised stock options to acquire 2,530 shares of Class A Common Stock at $5.01 per share on March 5, 2025.
Summary
- On March 5, 2025, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., exercised stock options.
- This transaction involved the acquisition of 2,530 shares of Class A Common Stock at a price of $5.01 per share.
- Following the reported transaction, Okupe directly owns 110,319 shares of Class A Common Stock.
- Okupe also holds derivative securities in the form of stock options, with 410,770 options beneficially owned after the transaction.
- The exercised stock options were part of an option grant that vests over time, with 25% vesting after one year from the Vesting Commencement Date of January 24, 2022, and the remainder vesting in equal monthly installments over the following 36 months.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction, and it doesn't convey any particularly positive or negative sentiment. It's a neutral disclosure of information.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions, which are common for executives who receive stock options as part of their compensation. It provides transparency into the trading activities of company insiders.
Comparison to Industry Standards
- Stock option grants and exercises are standard practice in publicly traded companies, particularly in the tech and healthcare sectors where Hims & Hers operates.
- Companies like Teladoc Health, GoodRx, and Amwell also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance and retention.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it's a routine exercise of stock options.
- It reflects the CFO's continued investment in the company's stock, which can be seen as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 01/24/2022 | Vesting Commencement Date for the stock options. |
| 02/23/2032 | Expiration date of the stock options. |
| 03/05/2025 | Date of the stock option exercise. |
| 03/06/2025 | Date of the signature on the Form 4 filing. |
Keywords
Form 4, Stock Options, Beneficial Ownership, Hims & Hers Health, Oluyemi Okupe, CFO, HIMS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.